Skip to content

Clinical trials

Triple Negative Breast Neoplasms trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Country / region: Mexico Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20183
20193
20202
20211
20223
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting6
Completed4
Recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
AstraZeneca2
Gilead Sciences2
Merck Sharp & Dohme LLC2
Amgen1
Bristol-Myers Squibb1
GlaxoSmithKline1
Novartis Pharmaceuticals1
OBI Pharma, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms16
Breast Neoplasms5
Adenocarcinoma of Lung1
Breast Diseases1
Carcinoma, Ovarian Epithelial1
Cholangiocarcinoma1
Neoplasms1
Neoplasms by Site1
Skin Diseases1
Squamous Cell Carcinoma of Head and Neck1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.